Houda Hachad, VP of Clinical Operations at Aranscia, AccessDx Laboratory’s parent company, is a co-author of the recent paper titled, “PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting.”
Per the paper, “This PharmVar tutorial offers practical guidance on how to detect the many, often complex, structural variants, as well as recommends terms and definitions for clinical and research reporting.”
To read the full paper in PubMed, click here: https://pubmed.ncbi.nlm.nih.gov/37669183/
